K Nakazato Selected Research

K Nakazato Research Topics

2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2021 - 11/2001
2	Hypertrophy 05/2013 - 01/2012
2	Atherosclerosis 04/2001 - 01/2000
2	Syncope (Fainting) 01/2001 - 10/2000
1	Left Ventricular Dysfunction 06/2021
1	Muscular Atrophy (Muscle Atrophy) 05/2013
1	Intervertebral Disc Displacement (Herniated Disc) 07/2012
1	Intervertebral Disc Degeneration 09/2009
1	Body Weight (Weight, Body) 01/2007
1	Stable Angina 11/2001
1	Unstable Angina 11/2001
1	Myocardial Infarction 11/2001
1	Acute Coronary Syndrome 11/2001
1	Hypoxia (Hypoxemia) 04/2001
1	Necrosis 04/2001
1	Atrial Premature Complexes (Premature Atrial Contraction) 01/2001
1	Ventricular Fibrillation 01/2001
1	Brugada Syndrome 01/2001
1	Atrial Fibrillation 01/2001

3	Proteins (Proteins, Gene)FDA Link 01/2012 - 04/2001
2	Vasodilator Agents (Vasodilators)IBA 06/2021 - 10/2000
2	VLDL receptorIBA 04/2001 - 01/2000
2	Messenger RNA (mRNA)IBA 04/2001 - 04/2001
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 05/2013
1	AntioxidantsIBA 05/2013
1	Muscle Proteins (Muscle Protein)IBA 05/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2013
1	Collagen Type XIIBA 07/2012
1	Cadmium Chloride (Cadmium Dichloride)IBA 01/2007
1	Apolipoproteins AIBA 11/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2001
1	Plasminogen Activator Inhibitor 1IBA 11/2001
1	Apoprotein(a) (Apolipoprotein (a))IBA 11/2001
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2001
1	Lipoproteins (Lipoprotein)IBA 04/2001
1	oxidized low density lipoproteinIBA 04/2001
1	Interleukin-1beta (Interleukin 1 beta)IBA 04/2001
1	VLDL LipoproteinsIBA 04/2001
1	pilsicainideIBA 01/2001
1	Flecainide (Tambocor)FDA LinkGeneric 01/2001
1	Anti-Arrhythmia AgentsIBA 01/2001

1	Resistance Training 01/2012